Table 1

Baseline characteristics of study subjects. Included are the ITT population and those assessed in the secondary exploratory analyses. ADI-R, Autism Diagnostic Interview-Revised; SSRI/SNRI, selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor.

ITT
population
Subjects with
ABC-L/SW ≥8
Total6327
Age (years)
  6–112411
  12–17229
  18–40177
Sex (M/F)55/824/3
Race (>1 response permitted)
  Caucasian5525
  African-American30
  Other52
Ethnicity: Non-Hispanic/Hispanic58/525/2
Comorbid autism (DSM-IV and ADI-R criteria)3719
Concomitant psychoactive medication (any)5427
  Antipsychotics3016
  Psychostimulants189
  SSRI/SNRI2512
  Antiepileptics1210
IQ (mean ± SD)46 ± 847 ± 11